Using Morphine PRN with Scheduled Oxycodone

Rationale for Combination Use

The Centers for Disease Control and Prevention (CDC) recognizes specific situations where combining immediate-release and extended-release/long-acting opioids may be necessary, such as for temporary postoperative pain management in patients already receiving scheduled opioids 1, 2
For patients with cancer-related pain, using a short-acting opioid for breakthrough pain alongside a scheduled opioid regimen is an established practice, as recommended by the American Society of Clinical Oncology 3

When prescribing multiple opioids, consider the potential for increased overdose risk and use caution with dosing, as advised by the CDC 1
Calculate the total daily morphine equivalent dose (MED) of all opioids combined to ensure safety, according to the CDC guidelines 2
Monitor closely for signs of respiratory depression, especially during the initial period of combination therapy, as recommended by the CDC 1

Start with the lowest possible dose of morphine PRN to achieve acceptable analgesia, as recommended by the American Society of Clinical Oncology 3
When adding morphine PRN to a regimen that includes scheduled oxycodone, determine an appropriate PRN morphine dose, typically 10-20% of the 24-hour total opioid requirement 4

If the patient requires frequent breakthrough doses (more than 3 doses per day), consider increasing the regular scheduled oxycodone dose rather than continuing frequent PRN morphine, as suggested by the National Comprehensive Cancer Network 4
Consider patient-specific factors such as age, renal or hepatic function, and comorbidities when determining appropriate dosing, as recommended by the American Geriatrics Society 5